Valuation: Repligen Corporation

Market Cap 8.12B 7.1B 6.55B 6.06B 11.5B 775B 11.7B 78.44B 30.75B 381B 30.48B 29.82B 1,318B P/E 2026 *
132x
P/E 2027 * 80.1x
Enterprise Value 7.86B 6.88B 6.34B 5.87B 11.14B 751B 11.33B 75.98B 29.79B 369B 29.53B 28.89B 1,277B EV / Sales 2026 *
9.61x
EV / Sales 2027 * 8.15x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+4.75%
1 week+1.08%
Current month+5.50%
1 month+10.61%
3 months+20.17%
6 months-13.72%
Current year-12.16%
1 week 135.08
Extreme 135.08
144.58
1 month 124.85
Extreme 124.85
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Financial Officer

-733 0.0013%
05-14Free

Chairman

3,234 0.0057%
05-14Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+4.75%+1.08%+10.88%+1.70% 8.12B
-0.82%-1.05%-29.14%-11.24% 164B
+0.46%-0.96%-7.43%-4.07% 105B
-2.30%+2.01%+0.77%+58.47% 58.85B
+0.79%-3.68%+40.47%+55.85% 51.05B
+0.19%-4.57%-14.05%-41.29% 41.57B
+1.36%-5.42% - - 34.54B
-1.40%+2.48%-13.96%-42.37% 28.18B
+1.13%-2.21%+58.13%-3.75% 25.27B
-1.73%-3.06%-10.60%+1.91% 20.24B
Average +0.24%-0.90%+3.90%+1.69% 53.77B
Weighted average by Cap. -0.25%-0.72%-6.16%+2.11%

Financials

2026 *2027 *
Net sales 818M 716M 660M 611M 1.16B 78.1B 1.18B 7.9B 3.1B 38.35B 3.07B 3.01B 133B 943M 825M 761M 704M 1.34B 90.04B 1.36B 9.11B 3.57B 44.22B 3.54B 3.46B 153B
Net income 61.09M 53.44M 49.28M 45.6M 86.55M 5.83B 88M 590M 231M 2.86B 229M 224M 9.92B 101M 88.51M 81.62M 75.52M 143M 9.66B 146M 977M 383M 4.74B 380M 372M 16.43B
Net Debt -254M -223M -205M -190M -360M -24.29B -366M -2.46B -964M -11.93B -955M -935M -41.31B -432M -378M -348M -322M -612M -41.22B -622M -4.17B -1.64B -20.24B -1.62B -1.59B -70.12B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
09/07/26 US$143.94 +4.75% 667,210
08/07/26 US$137.41 -1.73% 689,024
07/07/26 US$139.83 -1.15% 617,789
06/07/26 US$141.46 -0.66% 666,683
02/07/26 US$142.40 +2.45% 985,760
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
143.94USD
Average target price
177.05USD
Spread / Average Target
+23.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock